作者: Manfred Uhr , Bertram Müller-Myhsok , Florian Holsboer
DOI:
关键词:
摘要: The present invention relates to methods, compositions, kits and reagents for determining the prognosis of a clinical response in human patient medicament which acts central nervous system (CNS) is substrate ABCB1 protein. Further, combination medicaments treatment patients having specific polymorphisms gene.